Evidence map›Paper›PMID 35438424›Full record

Trial reportEuropean journal of applied physiology2022

Maximal strength training in patients with inflammatory rheumatic disease: implications for physical function and quality of life.

Håvard Haglo, Ole Kristian Berg, Jan Hoff, Jan Helgerud, Eivind Wang

Registry-linked trialOpen access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in European journal of applied physiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04998955 (Maximal Strength Training in Patients With Inflammatory Rheumatic Disease), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04998955 nacompletednot on this map

Maximal Strength Training in Patients With Inflammatory Rheumatic Disease: Implications for Physical Function and Quality of Life

TypeinterventionalSponsorMolde University CollegeRan2018 to 2018Enrolled24ConditionsInflammatory RheumatismArmsMaximal strength training
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Håvard HagloFaculty of Health and Social Sciences, Molde University College, Molde, Norway. havard@treningsklinikken.no.ORCID http://orcid.org/0000-0001-7147-4463
Ole Kristian BergFaculty of Health and Social Sciences, Molde University College, Molde, Norway.
Jan HoffMyworkout, Medical Rehabilitation Clinic, Ingvald Ystgaards veg 23, 7047, Trondheim, Norway.
Jan HelgerudMyworkout, Medical Rehabilitation Clinic, Ingvald Ystgaards veg 23, 7047, Trondheim, Norway.
Eivind WangFaculty of Health and Social Sciences, Molde University College, Molde, Norway.
Molde University College · NONorwegian University of Science and Technology · NOSt Olav's University Hospital · NO

Funding

Norges Forskningsråd 305506
6 · The paper itself

Abstract

purposePatients with inflammatory rheumatic disease (IRD) have attenuated muscle strength in the lower extremities, resulting in impaired physical function and quality of life. Although maximal strength training (MST), applying heavy resistance, is documented to be a potent countermeasure for such attenuation, it is uncertain if it is feasible in IRD given the pain, stiffness, and joint swelling that characterize the population.

methods23 patients with IRD (49 ± 13 years; 20 females/3 males), diagnosed with spondyloarthritis, rheumatoid arthritis, or systemic lupus erythematosus, were randomized to MST or a control group (CG). The MST group performed four × four repetitions dynamic leg press two times per week for 10 weeks at ~ 90% of one repetition maximum (1RM). Before and after training 1RM, rate of force development (RFD), and health-related quality of life (HRQoL) were measured.

resultsSession attendance in the MST group was 95%, of which 95% conducted according to MST protocol. Furthermore, MST increased 1RM (29 ± 12%, p = 0.001) and early and late phase RFD (33-76%, p < 0.05). All improvements were different from the CG (p < 0.05). MST also resulted in HRQoL improvements in the dimensions; physical functioning, general health, and vitality (p < 0.05). Physical functioning was associated with 1RM (rho = 0.55, p < 0.01) and early phase RFD (rho = 0.53-0.71, p < 0.01; different from CG p < 0.05).

conclusionsDespite being characterized by pain, stiffness, and joint swelling, patients with IRD appear to tolerate MST well. Given the improvements in 1RM, RFD, and HRQoL MST should be considered as a treatment strategy to counteract attenuated muscle strength, physical function, and HRQoL.

trial registrationClinicalTrials.gov, NCT04998955, retrospectively registered.

Indexed as

Resistance TrainingRheumatic DiseasesFemaleHumansMaleMuscle StrengthPainQuality of LifeHeavy resistance trainingOne repetition maximumRate of force developmentRehabilitationRheumatoid arthritis

Identifiers

PMID35438424
PMCPMC9197881
OpenAlexW4224210334

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.